Biggest News Aggregation in the World
📰 Dexcom News

Page 94 - Dexcom News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dexcom. Real-time updates on events, politics, business and more.

NorthRock Partners LLC Sells 335 Shares of DexCom, Inc. (NASDAQ:DXCM)

NorthRock Partners LLC decreased its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 9.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,203 shares of the medical device company’s stock after selling 335 shares during the quarter. NorthRock Partners […]
United States Raymond James Stifel Nicolaus Exchange Commission Jpmorgan Chase Co Bank Julius Baer Co
Source: wkrb13.com

DexCom, Inc. (NASDAQ:DXCM) Receives $132.87 Average PT from Analysts

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have received a consensus rating of “Moderate Buy” from the sixteen analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, thirteen have given a buy recommendation and one has issued a strong buy recommendation […]
United States Jeremem Sylvain Piper Sandler Morgan Stanley Valeo Financial Advisors Securities Exchange Commission

Retirement Systems of Alabama Sells 26,111 Shares of DexCom, Inc. (NASDAQ:DXCM)

Retirement Systems of Alabama trimmed its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,101 shares of the medical device company’s stock after selling 26,111 shares during the quarter. Retirement […]
United States Leerink Partnrs Steven Robert Pacelli Raymond James Stevenr Altman Exchange Commission

DexCom (NASDAQ:DXCM) Given New $100.00 Price Target at JPMorgan Chase & Co.

DexCom (NASDAQ:DXCM – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $160.00 to $100.00 in a report issued on Tuesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical device company’s stock. Several other equities research analysts have also issued reports on the company. […]
United States Canaccord Genuity Group Rock Asset Management Dexcom Inc Jpmorgan Chase Co Resources Investment Advisors
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Leerink Partnrs Reaffirms Outperform Rating for DexCom (NASDAQ:DXCM)

Leerink Partnrs restated their outperform rating on shares of DexCom (NASDAQ:DXCM – Free Report) in a research report sent to investors on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for DexCom’s Q3 2023 earnings at $0.37 EPS, Q4 2023 earnings at $0.42 EPS, Q1 2024 earnings at $0.30 EPS, Q2 2024 earnings at $0.39 […]
United States Steven Robert Pacelli Leerink Partnrs Stifel Nicolaus Raymond James Stevenr Altman
Source: wkrb13.com

DexCom (NASDAQ:DXCM) Given Outperform Rating at Leerink Partnrs

Leerink Partnrs restated their outperform rating on shares of DexCom (NASDAQ:DXCM – Free Report) in a research note issued to investors on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for DexCom’s Q3 2023 earnings at $0.37 EPS, Q4 2023 earnings at $0.42 EPS, Q1 2024 earnings at $0.30 EPS, Q2 2024 earnings at $0.39 […]
United States Jeremem Sylvain Leerink Partnrs Securities Exchange Commission Bank Julius Baer Co Dexcom Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science